Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Protein profiling of non-malignant and malignant ascites by SELDI-TOF MS: proof of principle.

Braunschweig T, Krieg RC, Bar-Or R, Smeets D, Schwamborn K, Fogt F, Nagel H, Hemmerlein B, Wellmann A.

Int J Mol Med. 2009 Jan;23(1):3-8.

PMID:
19082501
2.

SELDI-TOF-MS of saliva: methodology and pre-treatment effects.

Schipper R, Loof A, de Groot J, Harthoorn L, Dransfield E, van Heerde W.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 15;847(1):45-53. Epub 2006 Oct 27.

PMID:
17070117
3.

Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.

Wu C, Wang Z, Liu L, Zhao P, Wang W, Yao D, Shi B, Lu J, Liao P, Yang Y, Zhu L.

J Gastroenterol Hepatol. 2009 Jan;24(1):55-62. doi: 10.1111/j.1440-1746.2008.05580.x. Epub 2008 Sep 24.

PMID:
18823443
4.

SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.

Geng X, Wang F, Li YG, Zhu GP, Zhang WM.

J Exp Clin Cancer Res. 2007 Dec;26(4):505-8.

PMID:
18365545
5.

Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ.

Am J Clin Oncol. 2008 Apr;31(2):133-9. doi: 10.1097/COC.0b013e318145b98b.

PMID:
18391596
6.
7.

[Establishment of diagnostic model of cerebrospinal protein fingerprint pattern for glioma and its clinical application].

Liu J, Zheng S, Yu JK, Yu XB, Liu WG, Zhang JM, Hu X.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2005 Mar;34(2):141-7. Chinese.

PMID:
15812888
8.

Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.

Yang YH, Zhang S, Cui JF, Lu B, Dong XH, Song XY, Liu YK, Zhu XX, Hu RM.

Diabet Med. 2007 Dec;24(12):1386-92.

PMID:
18042080
9.

Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments.

Harezlak J, Wang M, Christiani D, Lin X.

Bioinformatics. 2007 Sep 15;23(18):2441-8. Epub 2007 Jul 11.

PMID:
17626063
10.

The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.

Hong M, Zhang X, Hu Y, Wang H, He W, Mei H, Yu J, Guo T, Song S.

Thromb Res. 2009;123(3):556-64. doi: 10.1016/j.thromres.2008.05.019. Epub 2008 Jul 11.

PMID:
18620739
11.

Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.

Okamoto A, Yamamoto H, Imai A, Hatakeyama S, Iwabuchi I, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Mori K, Yamaya K, Ohyama C.

Oncol Rep. 2009 Jan;21(1):73-9.

PMID:
19082445
12.

[Tree analysis pattern of mass spectral urine profiles in differential diagnosis of bladder transitional cell carcinoma].

Wu DL, Zhang YF, Guan M, Liu WW, Xu YM, Jin SB, Zhang J, Jin CR, Lü Y.

Zhonghua Zhong Liu Za Zhi. 2007 Apr;29(4):274-7. Chinese.

PMID:
17760254
13.

Serum inflammatory protein profiles in patients with chronic rhinosinusitis undergoing sinus surgery: a preliminary analysis.

Becker AM, Das S, Xia Z, Liu Z, Adam BL, Kountakis SE.

Am J Rhinol. 2008 Mar-Apr;22(2):139-43. doi: 10.2500/ajr.2008.22.3151.

PMID:
18416969
14.

Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifing biomarkers of endometriosis.

Zhang H, Feng J, Chang XH, Li ZX, Wu XY, Cui H.

Chin Med J (Engl). 2009 Feb 20;122(4):373-6.

PMID:
19302738
15.

High-throughput quantitative profiling of serum N-glycome by MALDI-TOF mass spectrometry and N-glycomic fingerprint of liver fibrosis.

Kam RK, Poon TC, Chan HL, Wong N, Hui AY, Sung JJ.

Clin Chem. 2007 Jul;53(7):1254-63. Epub 2007 May 17.

16.

Mass spectrometric profiling - a diagnostic tool in fish?

Provan F, Bjørnstad A, Pampanin DM, Lyng E, Fontanillas R, Andersen OK, Koppe W, Bamber S.

Mar Environ Res. 2006 Jul;62 Suppl:S105-8. Epub 2006 Apr 7.

PMID:
16764920
17.

The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles.

Cadron I, Van Gorp T, Amant F, Vergote I, Moerman P, Waelkens E, Daemen A, Van De Plas R, De Moor B, Zeillinger R.

Anticancer Res. 2009 Apr;29(4):1039-45.

18.

[Detection of differentially expressed proteins in the semen of oligospermia patients by SELDI-TOF-MS technology].

Liu CB, Liang Y, Pan CQ, Zhang J.

Zhonghua Nan Ke Xue. 2009 Mar;15(3):232-6. Chinese.

PMID:
19452695
19.

Clinical proteomics in breast cancer: a review.

Gast MC, Schellens JH, Beijnen JH.

Breast Cancer Res Treat. 2009 Jul;116(1):17-29. doi: 10.1007/s10549-008-0263-3. Epub 2008 Dec 11. Review.

PMID:
19082706
20.

Monitoring the serological proteome: the latest modality in prostate cancer detection.

Mobley JA, Lam YW, Lau KM, Pais VM, L'Esperance JO, Steadman B, Fuster LM, Blute RD, Taplin ME, Ho SM.

J Urol. 2004 Jul;172(1):331-7.

PMID:
15201806

Supplemental Content

Support Center